The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ACLARIS THERAPEUTICS INC | COMM | 00461U105 | 18,032,789 | 1,144,939 | SH | SOLE | 1,144,939 | 0 | 0 | |||
AEROVATE THERAPEUTICS INC | COMM | 008064107 | 31,681,328 | 1,081,274 | SH | SOLE | 1,081,274 | 0 | 0 | |||
ALPINE IMMUNE SCIENCES INC | COMM | 02083G100 | 1,860,057 | 253,069 | SH | SOLE | 253,069 | 0 | 0 | |||
CABALETTA BIO, INC | COMM | 12674W109 | 4,502,854 | 486,795 | SH | SOLE | 486,795 | 0 | 0 | |||
COGENT BIOSCIENCES INC | COMM | 19240Q201 | 41,974,846 | 3,631,042 | SH | SOLE | 3,631,042 | 0 | 0 | |||
CYMABAY THERAPEUTICS INC | COMM | 23257D103 | 37,026,858 | 5,905,400 | SH | SOLE | 5,905,400 | 0 | 0 | |||
ELEVATION ONCOLOGY INC | COMM | 28623U101 | 273,971 | 288,390 | SH | SOLE | 288,390 | 0 | 0 | |||
ENTRADA THERAPEUTICS INC | COMM | 29384C108 | 7,908,592 | 584,955 | SH | SOLE | 584,955 | 0 | 0 | |||
GERON CORP | COMM | 374163103 | 36,752,717 | 15,187,073 | SH | SOLE | 15,187,073 | 0 | 0 | |||
IMMUNOVANT, INC | COMM | 45258J102 | 15,173,641 | 854,853 | SH | SOLE | 854,853 | 0 | 0 | |||
IVERIC BIO INC | COMM | 46583P102 | 110,071,336 | 5,141,118 | SH | SOLE | 5,141,118 | 0 | 0 | |||
KALVISTA PHARMACEUTICALS, INC | COMM | 483497103 | 22,953,546 | 3,395,495 | SH | SOLE | 3,395,495 | 0 | 0 | |||
KURA ONCOLOGY INC | COMM | 50127T109 | 17,667,397 | 1,423,642 | SH | SOLE | 1,423,642 | 0 | 0 | |||
MADRIGAL PHARMACEUTICALS INC | COMM | 558868105 | 83,607,674 | 288,054 | SH | SOLE | 288,054 | 0 | 0 | |||
MERUS BV | COMM | N5749R100 | 4,641,000 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | |||
MOONLAKE IMMUNOTHERAPEUTICS | COMM | 61559X104 | 10,500,000 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | |||
SILENCE THERAPEUTICS PLC | ADRS | 82686Q101 | 32,099,344 | 2,104,875 | SH | SOLE | 2,104,875 | 0 | 0 | |||
TYRA BIOSCIENCES INC | COMM | 90240B106 | 15,117,183 | 1,989,103 | SH | SOLE | 1,989,103 | 0 | 0 | |||
VECTIVBIO HOLDING AG | COMM | H9060V101 | 20,218,045 | 2,333,300 | SH | SOLE | 2,333,300 | 0 | 0 | |||
VENTYX BIOSCIENCES, INC | COMM | 92332V107 | 25,813,304 | 787,231 | SH | SOLE | 787,231 | 0 | 0 | |||
VIRIDIAN THERAPEUTICS, INC | COMM | 92790C104 | 28,731,248 | 983,610 | SH | SOLE | 983,610 | 0 | 0 |